Swedish biotech Elicera Therapeutics reported complete metabolic responses in eight of 12 patients treated with its ...

Over the past few years, Belgium’s argenx has become a biotech force to be reckoned with, driven by the success of its ...

Finnish biotech Desentum has raised €28 million in an oversubscribed equity round to advance three allergy immunotherapy ...

For CDMOs, flexible upstream platforms can help streamline process ­development while maintaining reproducibility and ...

Perfusion is here, and it is rewriting the rules of biologics and biosimilar manufacturing. What was once experimental has become industrial reality: scalable, robust, regulatorily accepted, and ...

Zealand Pharma shares fell about 4% in Thursday trading after new Phase 2 results for its Roche-partnered obesity drug petrelintide showed encouraging weight loss but a modest improvement in blood ...

Every Friday, The Leadership Edit follows people taking new roles across European biotech and what their moves may tell us ...

Paris-based Rivercell has raised $25 million (about €22 million) in seed funding to generate experimental data and build AI ...

France’s WhiteLab Genomics has raised $26 million (€23 million) in Series B financing to expand experimental validation of ...

Australian biopharma company CSL has entered an exclusive global partnership with Basel-based Alentis Therapeutics to ...

Genmab and AbbVie's bispecific antibody epcoritamab, added to R-CHOP chemoimmunotherapy, cut the risk of progression or death by 51% in a Phase 3 trial in newly diagnosed diffuse large B-cell lymphoma ...

Swiss biotech ADC Therapeutics has secured an $86.6 million (€77.5 million) financing agreement alongside debt and royalty ...